BioAmber (BIOA) Misses Q2 EPS by 7c

BioAmber (NYSE: BIOA) reported Q2 EPS of ($0.20), $0.07 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $4.43 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
• Cracker Barrel (CBRL) Tops Q3 EPS by 71c